Researchers investigated the early maturation of sound duration processing, a crucial auditory temporal feature.
Avalon’s latest biotech closes $58M round as it pursues treatments for autoimmune brain conditions
Arialys Therapeutics announced Tuesday that it tied the bow on a $58 million seed round to develop treatments specifically for brain disorders caused by immune